Faculty Opinions recommendation of Long-term effects of continuing adjuvant tamoxifen to 10 years versus stopping at 5 years after diagnosis of oestrogen receptor-positive breast cancer: ATLAS, a randomised trial.
Keyword(s):
Keyword(s):
Keyword(s):
Keyword(s):
2003 ◽
Vol 26
(3)
◽
pp. 163-168
◽
Keyword(s):
2016 ◽
Vol 160
(2)
◽
pp. 313-322
◽
2013 ◽
Vol 49
(6)
◽
pp. 1196-1204
◽
2010 ◽
Vol 11
(1)
◽
pp. 55-65
◽
2013 ◽
Vol 31
(15_suppl)
◽
pp. 5-5
◽
Keyword(s):